PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
about
PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
description
clinical trial
@en
klinisch onderzoek
@nl
name
PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
@en
type
label
PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
@en
prefLabel
PARP Inhibition for Triple Negative Breast Cancer (ER-/PR-/HER2-)With BRCA1/2 Mutations
@en
P6153
P1476
PARP Inhibition After Preopera ...... osier Oncology Group BRE09-146
@en
P3098
NCT01074970
P580
2010-02-01T00:00:00Z
P582
2018-12-01T00:00:00Z